Why is PROCRIT so expensive?: An Analysis of Anemia Medication Costs
•
4 min read
In 2022, the global market for erythropoiesis-stimulating agents (ESAs) like PROCRIT was valued at approximately $4.8 billion, a testament to the high demand and equally high cost of these vital medications. This article explores the multifaceted reasons why is PROCRIT so expensive, examining the key drivers that contribute to its premium price tag.
